Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ERH pseudogene 1 (ERHP1) is a pseudogene located on chromosome 7 (7q34) and is a non-protein-coding copy of the ERH gene[1][3]. Pseudogenes are genomic DNA sequences similar to normal genes but typically lack the ability to encode functional proteins due to mutations or alterations. No biological function or disease association has been reported for ERH pseudogene 1[1][3]. It is not a receptor, enzyme, or other class of actionable target, and there are no known drugs or therapeutic mechanisms relating to this pseudogene. There is no evidence supporting ERHP1 as a biomarker or as having roles in disease. Note: The term "ERH pseudogene 1" refers to a pseudogene, not an active therapeutic target. If you are seeking information on the functional ERH protein (Enhancer of rudimentary homolog), which is involved in transcription regulation, mRNA splicing, and genome integrity, that is a separate entity[1], and should not be conflated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ERH pseudogene 1 (ERHP1).